THE IMPACT OF THE COMPOSITION OF THE BONE-MARROW GRAFT ON ENGRAFTMENT AND GRAFT-VERSUS-HOST DISEASE
- 1 January 1983
- journal article
- research article
- Vol. 11 (10) , 967-973
Abstract
To study the impact of the composition of the bone-marrow graft on engraftment and graft-vs.-host disease (GvHD), the data on 29 patients with acute leukemia in remission and 11 patients with aplastic anemia was reviewed. All of them received bone-marrow grafts from HLA matched, MLC nonreactive, sibling donors and were nursed in laminar down-flow isolators with selective gut decontamination, and received GvHD prophylaxis with methotrexate. The number of nucleated cells in the marrow graft-kg body weight of the recipient had no relation with the rapidity of engraftment or with the occurrence and severity of GvHD. The number of hematopoietic progenitor cells (CFUc)/kg had a weak, but significant, correlation with both the number of neutrophils at day 30 post BMT [bone marrow-transplantation] and with the day at which the reticulocytes passed the 10.permill. level. The number of T cells/kg did not show any correlation with either the occurrence or the severity of GvHD. The concentration of hematopoietic progenitor cells in the graft apparently correlates with the rapidity of engraftment. However, within the range of numbers of T cells infused in this study, no correlation is present between T cells in the graft and GvHD. Therefore, nearly complete depletion of marrow grafts of T cells is probably necessary to effectively decrease the incidence of GvHD.This publication has 14 references indexed in Scilit:
- USE OF ANTI-T-CELL MONOCLONAL ANTIBODY OKT3 TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE LEUKAEMIAThe Lancet, 1982
- Bone marrow transplantation across major histocompatibility barriers. V. Protection of mice from lethal graft-vs.-host disease by pretreatment of donor cells with monoclonal anti-Thy-1.2 coupled to the toxin ricin.The Journal of Experimental Medicine, 1982
- Bone marrow transplantation across major histocompatability barriers in mice. III. Treatment of donor grafts with monoclonal antibodies directed against Lyt determinants.The Journal of Immunology, 1982
- ELIMINATION OF T‐LYMPHOCYTES FROM HUMAN BONE MARROW WITH MONOCLONAL T‐ANTIBODIES AND CYTOLYTIC COMPLEMENTBritish Journal of Haematology, 1982
- TRANSPLANTATION FOR ACUTE LEUKAEMIA WITH HLA-A AND B NONIDENTICAL PARENTAL MARROW CELLS FRACTIONATED WITH SOYBEAN AGGLUTININ AND SHEEP RED BLOOD CELLSThe Lancet, 1981
- Selective Antimicrobial Modulation of Human Microbial Flora: Infection Prevention in Patients with Decreased Host Defense Mechanisms by Selective Elimination of Potentially Pathogenic BacteriaThe Journal of Infectious Diseases, 1981
- Granulocyte Progenitor Compartments after Allogeneic Bone Marrow GraftsScandinavian Journal of Haematology, 1981
- ANTI-THYMOCYTE GLOBULIN EFFECTIVE IN THE TREATMENT OF APLASTIC-ANEMIA DOES NOT STIMULATE GRANULOCYTE PRECURSOR CELLS1981
- MYELOID PROGENITOR-CELL - ITS VALUE IN PREDICTING HEMATOPOIETIC RECOVERY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION1980
- Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.The Journal of Experimental Medicine, 1978